AXGN:NASDAQ
AxoGen, Inc Common Stock
$48.35
arrow_downward
-0.81%(-0.40) 1D
Nov 6, 11:12:38 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AXGN...
Open
$48.55
High
$49.16
Low
$48.14
Mkt. cap
2.89B
Avg. vol.
1.79M
Volume
109.67K
52-wk high
$52.91
52-wk low
$23.00
EPS
-$0.68
Beta
1.21
Shares outstanding
59.73M
No. of employees
622
Open
$48.55
High
$49.16
Low
$48.14
Mkt. cap
2.89B
Avg. vol.
1.79M
Volume
109.67K
52-wk high
$52.91
52-wk low
$23.00
EPS
-$0.68
Beta
1.21
Shares outstanding
59.73M
No. of employees
622
News stories
From web sources and news partners
qz.com
·
33 minutes ago
Stock futures explained: how Dow, S&P 500 and Nasdaq-100 contracts work
UA.NEWS
·
16 minutes ago
Nasdaq rises 1.23% after AI stock sell-off — BBC News
Yahoo Finance
·
1 hour ago
$3 trillion was wiped off the S&P 500 — but it ain't doomsday
TradingView
·
1 hour ago
Dow slides, Nasdaq gains as Wall Street reels from tech selloff
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersAlachua, Florida, United States
SectorHealth Care
IndustryMedical device
Websiteaxogeninc.com